- Published at
- by thestreet.com
neutral
neutral
Actinium And Astellas Announce Research Collaboration Focused On Novel Actinium-225 Based Targeted Radiotherapies
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced the research collaboration with